USANA Health Sciences Inc. (USNA)
NYSE: USNAHealth Care Medicinal Chemicals and Botanical Products USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
USNA stock chart
Technical analysisKey statistics
All statistics- Market cap
- $239.24M
- Forward P/E
- 10.35
- EPS (TTM)
- -$1.14
- Dividend yield
- None
- 52-week range
- 12.53 – 23.59
- Day range
- 12.88 – 13.43
- Volume / Avg
- 158.78K / 194.10K
- Beta
- —
- Shares outstanding
- 18.49M
52-week range
USNA stock today
USANA Health Sciences (USNA) closed at $12.94 on Nov 20, down 1.67% (-$0.22), versus the S&P 500's 3.70% decline. Shares are 45.1% below their 52-week high of $23.59, set on Jul 28, 2026 and 3.3% above the 52-week low of $12.53, near the bottom of the past year's range. USNA is down 34.1% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 34.1%.
USANA Health Sciences has posted a net loss over the last twelve months (EPS of -$1.14), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About USANA Health Sciences
Company profileUSANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer.
- Sector
- Health Care
- Industry
- Medicinal Chemicals and Botanical Products
- CEO
- Mr. Kevin G. Guest
- Headquarters
- Salt Lake City, UT
- Employees
- 1,570
- Website
- usana.com
Financial highlights
Full financialsIn fiscal 2025, USANA Health Sciences generated $925.3 million in revenue, up 8.3% from fiscal 2023. Net income was $10.8 million (-74.4% year over year), for a net margin of 1.2% versus a median of 6.9% in the prior 5 years. Gross margin was 78.3% (down from 81.1%) and operating margin 4.0%.
| Fiscal year | FY 2025 | FY 2023 | FY 2023 | FY 2022 | FY 2022 |
|---|---|---|---|---|---|
| Revenue | $925.26M | $854.50M | $921.01M | $998.60M | $1.19B |
| Growth | +8.28% | -7.22% | -7.77% | -15.83% | +4.57% |
| Net income | $10.76M | $42.03M | $63.79M | $69.35M | $116.50M |
| EPS (diluted) | $0.58 | $2.19 | $3.30 | $3.59 | $5.73 |
Analyst forecast
ForecastConsensus
none
Avg. price target
$22.00+70.02%
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 3, 2026
- EPS actual vs est.
- $-0.15 vs $0.11
- Surprise
- -236.36%
USNA news
All USNA news- USANA Health Sciences Consensus Price Target Cut 12% to $22.44NasdaqUSNA, HEI.A
- USANA Health Sciences Q3 26 Earnings Conference Call At 11:00 AM ETNasdaq
- USANA's Q3 Loss Narrows, Sales Decline 4%; FY26 Outlook LoweredNasdaqUSNA, UHAL.B
- USANA Health Sciences Q3 Loss DecreasesNasdaq
- USANA Health Sciences Reports Third Quarter 2026 ResultsBusiness Wire
- USANA BiOmega Earns ConsumerLab Seal of Approval for Quality and PurityPR Newswire
- USANA Schedules Third Quarter 2026 Earnings Release and Conference CallBusiness Wire
USANA Health Sciences peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ACBAurora Cannabis Inc. | 4.16 | -2.35% | $273.50M | vs USNA |
| TLRYTilray Brands Inc. | 1.89 | -8.70% | $279.32M | vs USNA |
| SNDLSNDL Inc. | 1.17 | -5.65% | $285.20M | vs USNA |
| MDWDMediWound Ltd. | 13.59 | +0.37% | $195.56M | vs USNA |
| CGCCanopy Growth Corporation | 0.427 | -9.97% | $191.99M | vs USNA |
| NAGENiagen Bioscience Inc. | 1.84 | -1.60% | $145.72M | vs USNA |
| GLASGlass House Brands Inc. Subordinate Voting Shares | 1.18 | -2.48% | $118.11M | vs USNA |
| ISPRIspire Technology Inc. | 1.23 | -3.15% | $71.05M | vs USNA |
Indexes, lists and sector
USANA Health Sciences stock FAQ
What is USANA Health Sciences's stock price today?
USNA last traded at $12.94 as of Nov 20, 4:00 PM EST, down 1.67% on the day. Prices are delayed at least 15 minutes.
Does USANA Health Sciences pay a dividend?
No. USANA Health Sciences does not currently pay a regular cash dividend.
Who is USANA Health Sciences's CEO?
Mr. Kevin G. Guest is the chief executive officer of USANA Health Sciences Inc., which has about 1,570 employees.
Has USNA ever split its stock?
Yes. The most recent USNA stock split was a 2-for-1 split on Nov 23, 2016, one of 3 splits on record.
What is the USNA 52-week high?
The 52-week high for USNA is $23.59 and the 52-week low is $12.53. The stock is currently 45.1% below its high.